These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 12616029

  • 1. Treating IgA Nephropathy - Who, When and How?
    Feehally J.
    Nephron Clin Pract; 2003; 93(2):C47-8. PubMed ID: 12616029
    [No Abstract] [Full Text] [Related]

  • 2. Effects of Two Immunosuppressive Treatment Protocols for IgA Nephropathy.
    Rauen T, Fitzner C, Eitner F, Sommerer C, Zeier M, Otte B, Panzer U, Peters H, Benck U, Mertens PR, Kuhlmann U, Witzke O, Gross O, Vielhauer V, Mann JFE, Hilgers RD, Floege J.
    J Am Soc Nephrol; 2018 Jan; 29(1):317-325. PubMed ID: 29042456
    [Abstract] [Full Text] [Related]

  • 3. Glomerular disease: ACEIs with or without corticosteroids in IgA nephropathy?
    Eitner F, Floege J.
    Nat Rev Nephrol; 2010 May; 6(5):252-4. PubMed ID: 20424626
    [No Abstract] [Full Text] [Related]

  • 4. Combined immunosuppression in high-risk patients with IgA nephropathy?
    Floege J, Eitner F.
    J Am Soc Nephrol; 2010 Oct; 21(10):1604-6. PubMed ID: 20829408
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of IgA nephropathy.
    Pozzi C.
    J Nephrol; 2016 Feb; 29(1):21-5. PubMed ID: 26577268
    [Abstract] [Full Text] [Related]

  • 6. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
    Manno C, Torres DD, Rossini M, Pesce F, Schena FP.
    Nephrol Dial Transplant; 2009 Dec; 24(12):3694-701. PubMed ID: 19628647
    [Abstract] [Full Text] [Related]

  • 7. IgA nephropathy: a disease in search of a large-scale clinical trial to reliably inform practice.
    Strippoli GF, Maione A, Schena FP, Tognoni G, Craig JC.
    Am J Kidney Dis; 2009 Jan; 53(1):5-8. PubMed ID: 19101396
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of antiproteinuric effects of two different combination therapies in children with IgA nephropathy.
    Yagi K, Okada M, Yanagida H, Kuwajima H, Ikeda M, Sugimoto K, Takemura T.
    Clin Exp Nephrol; 2003 Dec; 7(4):270-4. PubMed ID: 14712355
    [Abstract] [Full Text] [Related]

  • 9. IgA nephropathy with severe chronic renal failure: a randomized controlled trial of corticosteroids and azathioprine.
    Pozzi C, Andrulli S, Pani A, Scaini P, Roccatello D, Fogazzi G, Pecchini P, Rustichelli R, Finocchiaro P, Del Vecchio L, Locatelli F.
    J Nephrol; 2013 Dec; 26(1):86-93. PubMed ID: 22460183
    [Abstract] [Full Text] [Related]

  • 10. A comparison of the effectiveness of cyclophosphamide, leflunomide, corticosteroids, or conservative management alone in patients with IgA nephropathy: a retrospective observational study.
    Chen S, Yin Q, Ren S, Zhong X, Wang W, Li G, Wang L.
    Sci Rep; 2018 Sep 12; 8(1):13662. PubMed ID: 30209279
    [Abstract] [Full Text] [Related]

  • 11. Therapeutic approach of patients with IgA nephropathy.
    Goumenos DS, Brown CB.
    Ren Fail; 2004 Mar 12; 26(2):171-7. PubMed ID: 15287202
    [Abstract] [Full Text] [Related]

  • 12. Supportive Versus Immunosuppressive Therapy of Progressive IgA nephropathy (STOP) IgAN trial: rationale and study protocol.
    Eitner F, Ackermann D, Hilgers RD, Floege J.
    J Nephrol; 2008 Mar 12; 21(3):284-9. PubMed ID: 18587715
    [Abstract] [Full Text] [Related]

  • 13. IgA nephritis: ACE inhibitors, steroids, both or neither?
    Locatelli F, Pozzi C, Andrulli S.
    Nephrol Dial Transplant; 2006 Dec 12; 21(12):3357-61. PubMed ID: 16980324
    [No Abstract] [Full Text] [Related]

  • 14. IgA nephropathy and inhibitors of the renin angiotensin system: is reduction in proteinuria adequate proof of efficacy?
    Reddan DN, Owen WF.
    Am J Kidney Dis; 2001 Jul 12; 38(1):182-5. PubMed ID: 11431200
    [No Abstract] [Full Text] [Related]

  • 15. Corticosteroids plus ACE inhibitors for IgA nephropathy.
    Bourry E, Gharbi C, Izzedine H.
    Nephrol Dial Transplant; 2010 Apr 12; 25(4):1351; author reply 1351-2. PubMed ID: 20157171
    [No Abstract] [Full Text] [Related]

  • 16. [Therapeutic effects of RAS inhibitor in IgA nephropathy].
    Kashihara N.
    Nihon Jinzo Gakkai Shi; 2008 Apr 12; 50(4):473-7. PubMed ID: 18546877
    [No Abstract] [Full Text] [Related]

  • 17. Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial.
    Pozzi C, Andrulli S, Del Vecchio L, Melis P, Fogazzi GB, Altieri P, Ponticelli C, Locatelli F.
    J Am Soc Nephrol; 2004 Jan 12; 15(1):157-63. PubMed ID: 14694168
    [Abstract] [Full Text] [Related]

  • 18. [Management of IgA nephropathy].
    Amoroso L, De Sanctis L, Cappelli P, Di Vito R, Sirolli V, Bonomini M.
    G Ital Nefrol; 2011 Jan 12; 28(6):622-32. PubMed ID: 22167613
    [Abstract] [Full Text] [Related]

  • 19. [IgA nephropathy].
    Alamartine E.
    Rev Prat; 2003 Nov 30; 53(18):2023-6. PubMed ID: 15008216
    [Abstract] [Full Text] [Related]

  • 20. Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial.
    Lv J, Zhang H, Chen Y, Li G, Jiang L, Singh AK, Wang H.
    Am J Kidney Dis; 2009 Jan 30; 53(1):26-32. PubMed ID: 18930568
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.